Veterinary Pharmacovigilance Global Market Report 2026
상품코드:1938745
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
수의약 약물감시 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 9억 1,000만 달러에서 2026년에는 10억 3,000만 달러로, CAGR 13.1%로 성장이 전망되고 있습니다. 지난 수년간의 성장 요인으로는 수의학 분야의 공식적인 약물감시 체계의 부족, 동물용 의약품 사용 증가, 반려동물 건강관리 비용 증가, 동물의 약물 부작용 사례 증가, 약물 안전성 모니터링에 대한 규제 요건 등을 들 수 있습니다.
수의약 약물감시 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 16억 7,000만 달러에 달하며, CAGR은 12.7%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 세계 동물용 의약품 규제 강화, 생물제제 및 항감염제 개발 증가, 의약품 안전성 모니터링 활동의 아웃소싱 확대, 실시간 안전성 모니터링 솔루션에 대한 수요 증가, 가축 및 반려동물 개체수 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 동물용의약품의 안전성에 대한 규제 당국의 감시 강화, 의약품 안전성 모니터링 업무의 외부 위탁 증가, 동물용의약품 시판 후 조사에 대한 관심 증가, 부작용 보고 시스템 확대, 수의사의 의약품 안전성에 대한 의식의 향상 등을 들 수 있습니다.
동물용 의약품 및 의료 제품에 대한 수요 증가는 향후 수년간 동물용 의약품 약물감시 시장의 성장을 촉진할 것으로 예측됩니다. 동물용 의약품 및 의료 제품에는 의약품, 영양제, 미용 솔루션 등 동물의 건강과 복지를 유지 및 개선하는 것을 목적으로 하는 품목이 포함됩니다. 이러한 제품에 대한 수요 증가는 반려동물 사육 수 증가, 수의학 발전, 축산 생산성 향상의 필요성에 의해 촉진되고 있습니다. 또한 동물복지에 대한 인식이 높아지고 동물 질병 발생률이 높아진 것도 수요 증가에 더욱 기여하고 있습니다. 동물용의약품 안전성 모니터링은 지속적인 모니터링, 부작용 평가, 규제 준수를 통해 동물용의약품의 안전성과 유효성을 보장함으로써 애완동물 케어에 있으며, 중요한 역할을 합니다. 예를 들어 2024년 3월 에스토니아 공화국 의약품청(Ravimiamet)이 발표한 바에 따르면 2023년 동물용 의약품 시장은 전년 대비 6.9% 증가한 1,860만 유로로 2022년 1,740만 유로에서 증가했다고 합니다. 따라서 동물의 건강과 의약품에 대한 수요 증가는 동물용 의약품의 약물감시 시장 확대를 견인하고 있습니다.
동물용의약품 안전성 모니터링 시장에서 사업을 운영하는 주요 기업은 동물용의약품의 지속적인 안전성과 유효성을 확보하기 위해 부작용 보고 시스템(REAS) 및 안전성 보고서 작성을 포함한 데이터 분석 기술의 진보를 통해 규제 프레임워크 강화에 주력하고 있습니다. 부작용 보고 및 안전성 보고서 작성에는 동물용 의약품에 대한 유해 또는 예상치 못한 반응을 체계적으로 기록 및 분석하여 위험 평가 및 규제 요건 준수를 유지하는 프로세스가 포함됩니다. 예를 들어 2024년 8월 멕시코 정부 기관인 농업농촌개발부는 전국적인 동물용 의약품 안전성 모니터링 시스템을 구축했습니다. 멕시코 농업농촌개발부(SENASICA)가 개발한 이 모니터링 플랫폼은 멕시코내 동물용 의약품의 안전성, 품질, 유효성을 보장하는 것을 목적으로 합니다. 이 시스템은 제약사, 유통사, 동물병원, 수의사 등 이해관계자로부터 부작용 관련 데이터를 수집하여 잠재적 위험을 식별, 평가, 경감할 수 있도록 돕습니다. 또한 부작용 기록 및 유효성, 잔류기준, 환경영향 모니터링을 위한 수의약물감시 가이드라인(REAS)도 포함되어 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Veterinary pharmacovigilance is the field focused on detecting, assessing, understanding, and preventing adverse effects or other drug-related issues in animals. It involves monitoring and evaluating the safety and efficacy of veterinary medicines after their approval. The aim is to ensure that the benefits of these medicines outweigh the risks, thus promoting animal health and welfare while also protecting human health and the environment.
The main types of veterinary pharmacovigilance are in-house and outsourced. In-house pharmacovigilance involves the monitoring and assessment of adverse drug reactions and safety-related data conducted by the pharmaceutical or veterinary company itself. This includes the use of software and services for products such as biologics and anti-infectives. The scope covers various animal types, including companion animals, livestock, and others. End users of these services include veterinary hospitals, veterinary companies, and academic and research institutes.
Tariffs have moderately impacted the veterinary pharmacovigilance market by increasing costs associated with imported software platforms, data management tools, and consulting services. These effects are most noticeable in outsourced pharmacovigilance services and software solutions used by veterinary companies and CROs, particularly in North America, Europe, and Asia-Pacific regions. Higher operational costs may slow adoption among smaller firms. However, tariffs are encouraging regional service providers, local software development, and increased investment in in-house pharmacovigilance capabilities.
The veterinary pharmacovigilance market research report is one of a series of new reports from The Business Research Company that provides veterinary pharmacovigilance market statistics, including veterinary pharmacovigilance industry global market size, regional shares, competitors with a veterinary pharmacovigilance market share, detailed veterinary pharmacovigilance market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary pharmacovigilance industry. This veterinary pharmacovigilance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The veterinary pharmacovigilance market size has grown rapidly in recent years. It will grow from $0.91 billion in 2025 to $1.03 billion in 2026 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to limited formal pharmacovigilance frameworks in veterinary medicine, increasing use of veterinary pharmaceuticals, growth of companion animal healthcare spending, rising cases of adverse drug reactions in animals, regulatory mandates for drug safety monitoring.
The veterinary pharmacovigilance market size is expected to see rapid growth in the next few years. It will grow to $1.67 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to strengthening global veterinary drug regulations, increasing development of biologics and anti infectives, rising outsourcing of pharmacovigilance activities, growing demand for real-time safety monitoring solutions, expanding livestock and companion animal populations. Major trends in the forecast period include increasing regulatory scrutiny on veterinary drug safety, growing adoption of outsourced pharmacovigilance services, rising focus on post-marketing surveillance of veterinary drugs, expansion of adverse event reporting systems, increasing awareness of drug safety among veterinarians.
The increasing demand for animal health and medicinal products is expected to drive the growth of the veterinary pharmacovigilance market in the coming years. Animal health and medicinal products include items intended to maintain and improve the health and well-being of animals, such as medicines, nutritional products, and grooming solutions. The rising demand for these products is fueled by growing pet ownership, advancements in veterinary medicine, and the need to enhance livestock productivity. In addition, heightened awareness of animal welfare and a rising incidence of animal diseases are further contributing to increased demand. Veterinary pharmacovigilance plays a critical role in pet care by ensuring the safety and effectiveness of veterinary medicines through continuous monitoring, evaluation of adverse reactions, and regulatory compliance. For example, in March 2024, according to the Republic of Estonia's Agency of Medicines (Ravimiamet), a national regulatory authority, the veterinary medicinal products sector grew by 6.9% in 2023, reaching €18.6 million, up from €17.4 million in 2022. Therefore, the growing demand for animal health and medicinal products is driving the expansion of the veterinary pharmacovigilance market.
Major companies operating in the veterinary pharmacovigilance market are concentrating on strengthening regulatory frameworks through advancements in data analytics, including adverse event reporting systems (REAS) and safety report preparation, to ensure the continued safety and efficacy of veterinary drugs. Adverse event reporting and safety report preparation involve the systematic documentation and analysis of harmful or unexpected reactions to veterinary medicines to assess risks and maintain compliance with regulatory requirements. For instance, in August 2024, the Ministry of Agriculture and Rural Development, a Mexico-based government agency, launched a national veterinary pharmacovigilance system. This monitoring platform, developed by SENASICA, is designed to ensure the safety, quality, and effectiveness of veterinary drugs in Mexico. The system gathers data on adverse reactions from stakeholders such as pharmaceutical manufacturers, distributors, veterinary hospitals, and veterinarians to identify, evaluate, and mitigate potential risks. It also incorporates the veterinary pharmacovigilance guide (REAS) to document adverse reactions and monitor efficacy, residue limits, and environmental impacts.
In January 2024, Veterinary Pharmaceutical Solutions, a U.S.-based veterinary services company, acquired Diamond Animal Health, Inc. for an undisclosed amount. Through this acquisition, Veterinary Pharmaceutical Solutions aimed to broaden its product portfolio, strengthen its research and development capabilities, and improve operational efficiency within the animal health sector. Diamond Animal Health, Inc. is a U.S.-based contract manufacturing and research organization that provides regulatory affairs consulting services, including support for veterinary pharmacovigilance activities.
Major companies operating in the veterinary pharmacovigilance market are Accenture PLC, Zoetis Inc, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Covetrus Inc, IDEXX Laboratories, Inc., Ceva Sante Animale, Virbac SA, Merck Animal Health, Huvepharma EOOD, Norbrook Laboratories Ltd, ProPharma Group, ArisGlobal LLC, PQE Group, Chanelle Pharma Group Ltd, Clinvet International, Ennov SAS, Sarjen Systems Pvt. Ltd, PharSafer Associates Ltd, Medfiles Oy, Azierta Contract Science Support Consulting, Knoell Germany GmbH, Triveritas Ltd, Leon Research, Biologit, Indivirtus Group
North America was the largest region in the veterinary pharmacovigilance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary pharmacovigilance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the veterinary pharmacovigilance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The veterinary pharmacovigilance market consists of revenues earned by entities by providing services such as monitoring adverse drug reactions, assessing medication safety, collecting and analyzing safety data, conducting risk management, and ensuring regulatory compliance for veterinary medicines. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary pharmacovigilance market also includes sales of databases, reporting systems, safety assessment tools, and monitoring devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Veterinary Pharmacovigilance Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses veterinary pharmacovigilance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for veterinary pharmacovigilance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary pharmacovigilance market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type: In House; Outsourced
2) By Solution: Software; Services
3) By Drug Class: Biologics; Anti Infectives; Other Drug Classes
4) By Animal Type: Companion Animals; Livestock Animals; Other Animal Types
5) By End User: Veterinary Hospitals; Veterinary Companies; Academic And Research Institutes
Subsegments:
1) By In House: Internal Pharmacovigilance Departments; In-House Monitoring And Reporting Systems; Veterinary Adverse Event Management Software
2) By Outsourced: Third-Party Pharmacovigilance Services; Contract Research Organizations (CROs) For Pharmacovigilance; Pharmacovigilance Consulting And Support Services
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
4.1.3 Biotechnology, Genomics & Precision Medicine
4.1.4 Fintech, Blockchain, Regtech & Digital Finance
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Increasing Regulatory Scrutiny On Veterinary Drug Safety
4.2.2 Growing Adoption Of Outsourced Pharmacovigilance Services
4.2.3 Rising Focus On Post-Marketing Surveillance Of Veterinary Drugs
4.2.4 Expansion Of Adverse Event Reporting Systems
4.2.5 Increasing Awareness Of Drug Safety Among Veterinarians
5. Veterinary Pharmacovigilance Market Analysis Of End Use Industries
5.1 Veterinary Hospitals
5.2 Veterinary Pharmaceutical Companies
5.3 Contract Research Organizations (Cros)
5.4 Academic And Research Institutes
5.5 Regulatory And Drug Safety Authorities
6. Veterinary Pharmacovigilance Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Veterinary Pharmacovigilance Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Veterinary Pharmacovigilance PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Veterinary Pharmacovigilance Market Size, Comparisons And Growth Rate Analysis
7.3. Global Veterinary Pharmacovigilance Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Veterinary Pharmacovigilance Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Veterinary Pharmacovigilance Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9.7. Global Veterinary Pharmacovigilance Market, Sub-Segmentation Of Outsourced, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Third-Party Pharmacovigilance Services, Contract Research Organizations (CROs) For Pharmacovigilance, Pharmacovigilance Consulting And Support Services
10. Veterinary Pharmacovigilance Market Regional And Country Analysis
10.1. Global Veterinary Pharmacovigilance Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Veterinary Pharmacovigilance Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Veterinary Pharmacovigilance Market
12.1. China Veterinary Pharmacovigilance Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Veterinary Pharmacovigilance Market
13.1. India Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Veterinary Pharmacovigilance Market
14.1. Japan Veterinary Pharmacovigilance Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Veterinary Pharmacovigilance Market
15.1. Australia Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Veterinary Pharmacovigilance Market
16.1. Indonesia Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Veterinary Pharmacovigilance Market
17.1. South Korea Veterinary Pharmacovigilance Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Veterinary Pharmacovigilance Market
19.1. South East Asia Veterinary Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Veterinary Pharmacovigilance Market
20.1. Western Europe Veterinary Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Veterinary Pharmacovigilance Market
21.1. UK Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Veterinary Pharmacovigilance Market
22.1. Germany Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Veterinary Pharmacovigilance Market
23.1. France Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Veterinary Pharmacovigilance Market
24.1. Italy Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Veterinary Pharmacovigilance Market
25.1. Spain Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Veterinary Pharmacovigilance Market
26.1. Eastern Europe Veterinary Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Veterinary Pharmacovigilance Market
27.1. Russia Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Veterinary Pharmacovigilance Market
28.1. North America Veterinary Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Veterinary Pharmacovigilance Market
29.1. USA Veterinary Pharmacovigilance Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Veterinary Pharmacovigilance Market
31.1. South America Veterinary Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Veterinary Pharmacovigilance Market
32.1. Brazil Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Veterinary Pharmacovigilance Market
33.1. Middle East Veterinary Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Veterinary Pharmacovigilance Market
34.1. Africa Veterinary Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Veterinary Pharmacovigilance Market, Segmentation By Type, Segmentation By Solution, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Veterinary Pharmacovigilance Market Regulatory and Investment Landscape
36. Veterinary Pharmacovigilance Market Competitive Landscape And Company Profiles
36.1. Veterinary Pharmacovigilance Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Veterinary Pharmacovigilance Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Veterinary Pharmacovigilance Market Company Profiles
36.3.1. Accenture PLC Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Zoetis Inc Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Boehringer Ingelheim Animal Health Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Covetrus Inc Overview, Products and Services, Strategy and Financial Analysis
37. Veterinary Pharmacovigilance Market Other Major And Innovative Companies
IDEXX Laboratories, Inc., Ceva Sante Animale, Virbac SA, Merck Animal Health, Huvepharma EOOD, Norbrook Laboratories Ltd, ProPharma Group, ArisGlobal LLC, PQE Group, Chanelle Pharma Group Ltd, Clinvet International, Ennov SAS, Sarjen Systems Pvt. Ltd, PharSafer Associates Ltd, Medfiles Oy
38. Global Veterinary Pharmacovigilance Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Veterinary Pharmacovigilance Market
40. Veterinary Pharmacovigilance Market High Potential Countries, Segments and Strategies
40.1 Veterinary Pharmacovigilance Market In 2030 - Countries Offering Most New Opportunities
40.2 Veterinary Pharmacovigilance Market In 2030 - Segments Offering Most New Opportunities
40.3 Veterinary Pharmacovigilance Market In 2030 - Growth Strategies
